PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.01
0.01
Intervallo Annuale
0.01
1.35
Variazione giornaliera
-99.03%
Variazione Mensile
-99.08%
Variazione di 6 mesi
-99.07%
Variazione Annuale
-99.07%
Chiusura Precedente
1.1 4
Open
0.0 1
Minimo
0.0 1
High
0.0 1
Volume
5
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 128.95 K
  • Employee 6
  • Founded 2011
  • CEO N/A
  • Website www.phiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG0024FKD97
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.72
Rapporto prezzo/fatturato
—

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Notizie